Negative feedback regulation of T helper type 1 (Th1)/Th2 cytokine balance via dendritic cell and natural killer T cell interactions

Blood

Volumn 106, Issue 5, 2005, Pages 1685-1693

  Minami, Keita ^b   Yanagawa, Yoshiki ^b   Iwabuchi, Kazuya ^b   Shinohara, Nobuo ^b   Harabayashi, Toru ^b   Nonomura, Katsuya ^b   Onoé, Kazunori ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BONE MARROW CELL; CELL FUNCTION; CELL INTERACTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOLYSIS; DENDRITIC CELL; EXTRACELLULAR MATRIX; FEMALE; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR RECOGNITION; MOUSE; NATURAL KILLER CELL; NEGATIVE FEEDBACK; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; TH1 CELL; TH2 CELL;

EID: 23944522338     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2004-12-4738     Document Type: Article

References (49)

1. Godfrey DI, Hammond KJ, Poulton LD, Smyth MJ, Baxter AG. NKT cells: fact, functions and fallacies. Immunol Today. 2000;21:573-583.
2. Wilson MT, Singh AK, Poulton LD, Van Kaer L. Immunotherapy with ligands of natural killer T cells. Trends Mol Med. 2002;8:225-231.
3. - single-positive thymocyte subpopulation that expresses a highly skewed T-cell antigen receptor Vβ family. Proc Natl Acad Sci U S A. 1992;89:6506-6510.
4. - thymocyte with specific lymphokine secretion. Eur J Immunol. 1993;23:307-310.
5. + thymocyte population associated with intact Fas expression on the target. J Exp Med. 1994;180:423-432.
6. Kawano T, Cui J, Koezuka Y, et al. CD1d-restricted and TCR-mediated activation of Vα 14 NKT cells by glycosylceramides. Science. 1997;278:1626-1629.
7. Singh N, Hong S, Scherer DC, et al. Activation of NKT cells by CD1d and α-galactosylceramide directs conventional T cells to the acquisition of a Th2 phenotype. J Immunol. 1999;163:2373-2377.
8. Miyamoto K, Miyake S, Yamamura T. A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells. Nature. 2001;413:531-534.
9. Illés Z, Kondo T, Newcombe J, Oka N, Tabira T, Yamamura T. Differential expression of NK T cell Vα24JαQ invariant TCR chain in the lesions of multiple sclerosis and chronic inflammatory demyelinating polyneuropathy. J Immunol. 2000;164:4375-4381.
10. Steinman RM. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol. 1991;9:271-296.
11. Hart DN. Dendritic cells: unique leukocyte populations which control the primary immune response. Blood. 1997;90:3245-3287.
12. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature. 1998;392:245-251.
13. + regulatory T cells by antigen-processing dendritic cells. J Exp Med. 2003;198:235-247.
14. Kikuchi K, Yanagawa Y, Aranami T, Iwabuchi C, Iwabuchi K, Onoé K. Tumour necrosis factor-α but not lipopolysaccharide enhances preference of murine dendritic cells for TH2 differentiation. Immunology. 2003;108:42-49.
15. Caron G, Delneste Y, Roelandts E, et al. Histamine polarizes human dendritic cells into Th2 cell-promoting effector dendritic cells. J Immunol. 2001;167:3682-3686.
16. Mazzoni A, Young HA, Spitzer JH, Visintin A, Segal DM. Histamine regulates cytokine production in maturing dendritic cells, resulting in altered T cell polarization. J Clin Invest. 2001;108:1865-1873.
17. Kalinski P, Hilkens CM, Snijders A, Snijdewint FG, Kapsenberg ML. IL-12-deficient dendritic cells, generated in the presence of prostaglandin E2, promote type 2 cytokine production in maturing human naive T helper cells. J Immunol. 1997;159:28-35.
18. Agrawal S, Agrawal A, Doughty B, et al. Different Toll-like receptor agonists instruct dendritic cells to induce distinct Th responses via differential modulation of extracellular signal-regulated kinase-mitogen- activated protein kinase and c-Fos. J Immunol. 2003;171:4984-4989.
19. Dillon S, Agrawal A, Van Dyke T, et al. A Toll-like receptor 2 ligand stimulates Th2 responses in vivo, via induction of extracellular signal-regulated kinase mitogen-activated protein kinase and c-Fos in dendritic cells. J Immunol. 2004;172:4733-4743.
20. Inaba K, Turley S, Iyoda T, et al. The formation of immunogenic major histocompatibility complex class II-peptide ligands in lysosomal compartments of dendritic cells is regulated by inflammatory stimuli. J Exp Med. 2000;191:927-936.
21. Fujii S, Shimizu K, Kronenberg M, Steinman RM. Prolonged IFN-γ-producing NKT response induced with α-galactosylceramide- loaded DCs. Nat Immunol. 2002;3:867-874.
22. Yanagawa Y, Iijima N, Iwabuchi K, Onoé K. Activation of extracellular signal-related kinase by TNF-α controls the maturation and function of murine dendritic cells. J Leukoc Biol. 2002;71:125-132.
23. Winzler C, Rovere P, Rescigno M, et al. Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures. J Exp Med. 1997;185:317-328.
24. Yanagawa Y, Onoé K. CCL19 induces rapid dendritic extension of murine dendritic cells. Blood. 2002;100:1948-1956.
25. Granucci F, Petralia F, Urbano M, et al. The scavenger receptor MARCO mediates cytoskeleton rearrangements in dendritic cells and microglia. Blood. 2003;102:2940-2947.
26. Yanagawa Y, Onoé K. CCR7 ligands induce rapid endocytosis in mature dendritic cells with concomitant up-regulation of Cdc42 and Rac activities. Blood. 2003;101:4923-4929.
27. Finkelman FD, Madden KB, Morris SC, et al. Anticytokine antibodies as carrier protein. J Immunol. 1993;151:1235-1244.
28. Shea-Donohue T, Sullivan C, Finkelman FD, et al. The role of IL-4 in Heligmosomoides polygyrus-induced alterations in murine intestinal epithelial cell function. J Immunol. 2001;167:2234-2239.
29. Madden KB, Whitman L, Sullivan C, et al. Role of STAT6 and mast cells in IL-4- and IL-13-induced alterations in murine intestinal epithelial cell function. J Immunol. 2002;169:4417-4422.
30. Strait RT, Morris SC, Smily K, Urban Jr JF, Finkelman FD. IL-4 exacerbates anaphylaxis. J Immunol. 2003;170:3835-3842.
31. - NK-like cells in the thymus. Blood. 2001;97:1765-1775.
32. Maeda M, Lohwasser S, Yamamura T, Takei F. Regulation of NKT cells by Ly49: analysis of primary NKT cells and generation of NKT cell line. J Immunol. 2001;167:4180-4186.
33. Taniguchi M, Harada M, Kojo S, Nakayama T, Wakao H. The regulatory role of Vα14 NKT cells in innate and acquired immune response. Annu Rev Immunol. 2003;21:483-513.
34. Nakagawa R, Motoki K, Ueno H, et al. Treatment of hepatic metastasis of the Colon26 adenocarcinoma with an α-galactosylceramide, KRN7000. Cancer Res. 1998;58:1202-1207.
35. Toura I, Kawano T Akutsu Y, Nakayama T, Ochiai T, Taniguchi M. Inhibition of experimental tumor metastasis by dendritic cells pulsed with α-galactosylceramide. J Immunol. 1999;163:2387-2391.
36. Rissoan MC, Soumelis V, Kadowaki N, et al. Reciprocal control of T helper cell and dendritic cell differentiation. Science. 1999;283:1183-1187.
37. Hochrein H, O'Keeffe M, Luft T, et al. Interleukin (IL)-4 is a major regulatory cytokine governing bioactive IL-12 production by mouse and human dendritic cells. J Exp Med. 2000;192:823-833.
38. Brasel K, De Smedt T, Smith JL, Maliszewski CR. Generation of murine dendritic cells from flt3-ligand-supplemented bone marrow cultures. Blood. 2000;96:3029-3039.
39. Ota T, Takeda K, Akiba H, et al. IFN-γ-mediated negative feedback regulation of NKT cell function by CD94/NKG2. Blood. Prepublished on March 3, 2005, as DOI 10.1182/blood-2004-11-4257.
40. + T cells. J Immunol. 1999;162:7067-7074.
41. Leite-De-Moraes MC, Hameg A, Pacilio M, et al. IL-18 enhances IL-4 production by ligand-activated NKT lymphocytes: a pro-Th2 effect of IL-18 exerted through NKT cells. J Immunol. 2001;166:945-951.
42. + T cells in the induction of immunoglobulin E antibodies in response to interleukin 18 treatment of mice. J Exp Med. 2003;197:997-1005.
43. Kurre P, Anandakumar P, Grompe M, Kiem HP. In vivo administration of interferon γ does not cause marrow aplasia in mice with a targeted disruption of FANCC. Exp Hematol. 2002;30:1257-1263.
44. Brigl M, Brenner MB. CD1: antigen presentation and T cell function. Annu Rev Immunol. 2004;22:817-890.
45. Hayakawa Y, Takeda K, Yagita H, et al. Critical contribution of IFN-γ and NK cells, but not perforin-mediated cytotoxicity, to anti-metastatic effect of α-galactosylceramide. Eur J Immunol. 2001;31:1720-1727.
46. Smyth MJ, Cretney E, Takeda K, et al. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon γ-dependent natural killer cell protection from tumor metastasis. J Exp Med. 2001;193:661-670.
47. + T cells and natural killer cells is essential for the anti-metastatic effect of α-galactosylceramide. Blood. 2002;99:1259-1266.
48. Kawano T, Cui J, Koezuka Y, et al. Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Vα 14 NKT cells. Proc Natl Acad Sci U S A. 1998;95:5690-5693.
49. + thymocytes. J Immunol. 1993;151:546-555.